Pharma Archives - Page 42 of 83 - Life Sciences Times

QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer

November 10, 2025

Strand Therapeutics Promotes Prashant Nambiar to Chief Scientific Officer and Appoints Ethan Cash as Senior Vice President, Head of Portfolio Management and Program Development

November 5, 2025

Pan-Mass Challenge Donates Record $78 Million to Dana-Farber Cancer Institute

November 3, 2025

THIS WEEK'S STORIES

City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant

November 10, 2025

Countable Labs Expands Countable PCR with New RNA Module to Advance Translational Research, Cell and Gene Therapy Manufacturing, and Diagnostic Development

November 4, 2025

VideaHealth and Henry Schein One Introduce Impact Panel for Dentrix and Dentrix Ascend

November 5, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant

AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome

Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart

Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis

Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration

Most Read

Tandem Mobi Receives FDA Clearance for Use with Android Smartphones

Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals

Dr. Nina Kottler Named Chief Medical AI Officer of Mosaic Clinical Technologies

Kaneka Expands Global Availability of i-ED Coil with European Launch

EDITOR PICKS

QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer

Strand Therapeutics Promotes Prashant Nambiar to Chief Scientific Officer and Appoints Ethan Cash as Senior Vice President, Head of Portfolio Management and Program Development

Pan-Mass Challenge Donates Record $78 Million to Dana-Farber Cancer Institute

THIS WEEK'S STORIES

City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant

Countable Labs Expands Countable PCR with New RNA Module to Advance Translational Research, Cell and Gene Therapy Manufacturing, and Diagnostic Development

VideaHealth and Henry Schein One Introduce Impact Panel for Dentrix and Dentrix Ascend

POPULAR CATEGORY

ABOUT US

FOLLOW US